Curious if that move is warranted. I get it's a big removal of a potential key competitor. But, couldn't the fail read through to ASND's ongoing pivotal trials as well?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.